Search Results - Hasumati Rahalkar
- Showing 1 - 2 results of 2
-
1
Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines by Hasumati Rahalkar, Hasumati Rahalkar, Hacer Coskun Cetintas, Sam Salek
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices by Hasumati Rahalkar, Hasumati Rahalkar, Alan Sheppard, Sam Salek, Sam Salek
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book